123 Results

People

  1. Motzer
    Motzer
  2. Saltz
    Saltz
  3. Dickler
    Dickler
  4. Jaimes
    Jaimes
  5. Glezerman
    Glezerman
  6. Miller
    Miller
  7. Aghajanian
    Aghajanian
  8. Flombaum
    Flombaum
  9. Hudis
    Hudis
  10. Lichtman
    Lichtman

Groups

  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (23)
  4. Division of Subspecialty Medicine (17)
  5. Renal (16)
  6. Gastrointestinal Oncology Service (15)
  7. Gynecologic Medicine Service (13)
  8. Center for Hematologic Malignancies (12)
  9. Hematologic Malignancies, Division of (12)
  10. Survivorship Research (12)
  1. "proteinuria"
Formats
  1. Journal Article (116)
  2. Review (3)
  3. Book Section (2)
  4. Research Letter (2)
Groups
  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (23)
  4. Division of Subspecialty Medicine (17)
  5. Renal (16)
  6. Gastrointestinal Oncology Service (15)

More Groups

People
  1. Robert Motzer (19)
  2. Leonard Saltz (8)
  3. Ilya Glezerman (7)
  4. Edgar Jaimes (6)
  5. Maura Dickler (6)
  6. Vincent Miller (5)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (5)
  3. Lancet Oncology (5)
  4. The Oncologist (4)
  5. Annals of Oncology (3)
  6. Cancer Science (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Oxford University Press (12)
  3. American Society of Clinical Oncology (11)
  4. Elsevier Science, Inc. (8)
  5. Nature Publishing Group (8)
  6. Wiley Blackwell (7)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity
    Journal Article

    Calizo, R. C.; Bhattacharya, S.; van Hasselt, J. G. C.; Wei, C.; Wong, J. S.; Wiener, R. J.; Ge, X.; Wong, N. J.; Lee, J. J.; Cuttitta, C. M.; more...
    Nature Communications (2019)

    Fulltext@MSK | Save
  • A phase I/Ib trial of the VEGFR-sparing multikinase RET inhibitor RXDX-105
    Journal Article

    Drilon, A.; Fu, S.; Patel, M. R.; Fakih, M.; Wang, D.; Olszanski, A. J.; Morgensztern, D.; Liu, S. V.; Cho, B. C.; Bazhenova, L.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): A double-blind, randomised, placebo-controlled, phase 3 trial
    Journal Article

    Fuchs, C. S.; Shitara, K.; Di Bartolomeo, M.; Lonardi, S.; Al-Batran, S. E.; Van Cutsem, E.; Ilson, D. H.; Alsina, M.; Chau, I.; Lacy, J.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Case of proteinuria, worsening hypertension, and glomerular endotheliosis with erlotinib and gefitinib
    Journal Article

    Latcha, S.; Jaimes, E. A.; Gutgarts, V.; Seshan, S.
    Kidney International Reports (2018)

    Fulltext@MSK | Save
  • Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial
    Journal Article

    Guo, J.; Jin, J.; Oya, M.; Uemura, H.; Takahashi, S.; Tatsugami, K.; Rha, S. Y.; Lee, J. L.; Chung, J.; Lim, H. Y.; more...
    Journal of Hematology & Oncology (2018)

    Fulltext@MSK | Save
  • A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
    Journal Article

    Voss, M. H.; Hussain, A.; Vogelzang, N.; Lee, J. L.; Keam, B.; Rha, S. Y.; Vaishampayan, U.; Harris, W. B.; Richey, S.; Randall, J. M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Genetic predisposition to bevacizumab-induced hypertension
    Journal Article

    Frey, M. K.; Dao, F.; Olvera, N.; Konner, J. A.; Dickler, M. N.; Levine, D. A.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Paraprotein-related kidney disease: Diagnosing and treating monoclonal gammopathy of renal significance
    Journal Article

    Rosner, M. H.; Edeani, A.; Yanagita, M.; Glezerman, I. G.; Leung, N.; for the American Society of Nephrology Onco-Nephrology Forum
    Clinical Journal of the American Society of Nephrology (2016)

    Fulltext@MSK | Save
  • Association between probiotic and yogurt consumption and kidney disease: Insights from NHANES
    Journal Article

    Yacoub, R.; Kaji, D.; Patel, S. N.; Simoes, P. K.; Busayavalasa, D.; Nadkarni, G. N.; He, J. C.; Coca, S. G.; Uribarri, J.
    Nutrition Journal (2016)

    Fulltext@MSK | Save
  • D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
    Journal Article

    Valleix, S.; Verona, G.; Jourde-Chiche, N.; Nédelec, B.; Mangione, P. P.; Bridoux, F.; Mangé, A.; Dogan, A.; Goujon, J. M.; Lhomme, M.; more...
    Nature Communications (2016)

    Fulltext@MSK | Save